Stockreport

Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD) [Yahoo! Finance]

Lipocine Inc.  (LPCN) 
Last lipocine inc. earnings: 11/12 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.lipocine.com
PDF No drug discontinuations, excessive sedation, loss of consciousness, or drug-related SAEs reported Study is no longer screening new participants SALT LAKE CITY Jan. [Read more]